Clinical Trials | April 05, 2022
Dr Lal PathLabs to use drones for sample collection and diagnostic access
Pilots to be launched across multiple locations in India.
Pilots to be launched across multiple locations in India.
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step
Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Subscribe To Our Newsletter & Stay Updated
